Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
The accelerated review covers WCK 5222 for multiple critical infections
The interim efficacy readout, involving around 170 participants with 15-month data, remains on track for the end of March 2026
The funding will accelerate Sinopia’s data-driven drug discovery efforts
The agreement to sell B Medical Systems marks a major step forward in simplifying the portfolio to prioritize our core capabilities with the highest strategic impact
INOVIO remains confident in the therapy’s benefits and intends to meet with the FDA to discuss maintaining eligibility under this pathway
Subscribe To Our Newsletter & Stay Updated
